I. A. Zolotovskaya, V. D. Sabanova, & I. L. Davydkin. (2021). The Role of Rivaroxaban in a Comprehensive Protection Strategy for Patients with Atrial Fibrillation. Столичная издательская компания.
Chicago Style (17th ed.) CitationI. A. Zolotovskaya, V. D. Sabanova, and I. L. Davydkin. The Role of Rivaroxaban in a Comprehensive Protection Strategy for Patients with Atrial Fibrillation. Столичная издательская компания, 2021.
MLA (9th ed.) CitationI. A. Zolotovskaya, et al. The Role of Rivaroxaban in a Comprehensive Protection Strategy for Patients with Atrial Fibrillation. Столичная издательская компания, 2021.
Warning: These citations may not always be 100% accurate.